联环药业：接受光大证券等投资者调研

Group 1 - Company Lianhuan Pharmaceutical announced that on October 14, 2025, it will accept an investor survey conducted by Everbright Securities, with participation from the company's general manager, Niu Ben, who will address investor inquiries [1] Group 2 - The silver leasing market is experiencing a significant opportunity, with annualized interest rates soaring to 35%, indicating a strong demand for silver as it is being airlifted to the UK for profit [1]